The evolution of species is a complex phenomenon based on the optimization of a multidimensional function referred to as fitness. At the level of biomolecular evolution, the fitness function can be reduced to include physiochemical properties relevant to the biological function of a particular molecule. In this work, questions involving the physical-chemical mechanisms underlying the evolution of HIV-1 protease are addressed through molecular simulation and subsequent analysis of thermodynamic properties related to the activity of the enzyme. Specifically, the impact of 40 single amino acid mutations on the binding affinity toward the matrix/capsid (MA/CA) substrate and corresponding transition state intermediate has been characterized usin...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
strates with single amino acid substitutions at positions from P4 to P3 ' were built and compar...
Despite a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations in...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The binding mechanism of a peptide substrate (Thr-Ile-Met-Met-Gln-Arg, cleavage site p2-NC of the vi...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
Investigating the relationships between protein function and fitness provides keys for understanding...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
The emergence of compensatory drug-resistant mutations in HIV-1 protease challenges the common view ...
AbstractThe mechanism of the first steps of the reaction catalyzed by HIV-1 protease was studied thr...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
HIV-1 protease (PR) permits viral maturation by processing the Gag and Gag-Pro-Pol polyproteins. Tho...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
strates with single amino acid substitutions at positions from P4 to P3 ' were built and compar...
Despite a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations in...
The evolution of species is a complex phenomenon based on the optimization of a multidimensional fun...
The binding mechanism of a peptide substrate (Thr-Ile-Met-Met-Gln-Arg, cleavage site p2-NC of the vi...
Progress in understanding protein folding allows to simulate, with atomic detail, the evolution of a...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
Investigating the relationships between protein function and fitness provides keys for understanding...
HIV-1 protease recognizes and cleaves more than 12 different substrates leading to viral maturation....
The emergence of compensatory drug-resistant mutations in HIV-1 protease challenges the common view ...
AbstractThe mechanism of the first steps of the reaction catalyzed by HIV-1 protease was studied thr...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
HIV-1 protease (PR) permits viral maturation by processing the Gag and Gag-Pro-Pol polyproteins. Tho...
Despite of a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations...
Human immunodeficiency virus type 1 (HIV-1) protease (PR) permits viral maturation by processing the...
strates with single amino acid substitutions at positions from P4 to P3 ' were built and compar...
Despite a large number of antiretroviral drugs targeting HIV-1 protease for inhibition, mutations in...